🏢 官网IRQDELDoubao · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 20:00:00(美东 08:00)·⟳ 抓取 20:03:49回填·⚡ 决策 10-20 20:05:32·7.1 天前
QuidelOrtho（QDEL.US）宣布将于2026年11月3日盘后公布2026年三季度财报，属例行财报日期通知
这是上市公司标准的财报日期预告（save-the-date），全文不含任何业绩数字、指引调整、订单或经营信息，市场早已预期公司会在11月初常规披露Q3财报；无预期差、无可交易方向，财报真正发布（11月3日）才是催化事件。
📄 原文QDEL↗ 原文
QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
SAN DIEGO , Oct. 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global prov…
不做 QuidelOrtho Corporation（QDEL.US）
例行财报日期预告（11月3日盘后披露Q3），无业绩、指引或订单等任何增量信息，无预期差与方向；等待11月3日财报发布事件再研判，不据本通知下单。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
QuidelOrtho仅通知Q3财报将于11月3日盘后发布，无任何财务增量，属例行日程公告；对股价没有方向性新信息，不做。
关键理由
- 无做多或做空的基本面依据：稿件零财务数据、零指引、零订单，信息增量为空
主要风险
- 真正的变量在11月3日财报内容与指引，届时若超预期/不及预期才产生交易机会，本通知本身无edge
先例如何影响了这次决策
对本次决策的影响:确认本事件无交易edge，直接AVOID；真正需要先例校准的是11月3日财报本身
方向:财报日期预告属程序性事件，无方向性先例可资交易，不构成可统计的催化样本
涨幅量级:无可用于校准幅度的同类（财报日期通知）价格反应，因无基本面增量
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 15 ms
{"result": "search_processed_events:agent query=`quidelortho q3 2026 financial results conference call announcement | quidelortho qdel third quarter 2026 earnings date november 3 2026`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。
原文全文
展开原文 · 1,921 字
SAN DIEGO
,
Oct. 20, 2026
/PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will issue a press release to report its financial results for the third quarter 2026 ended September 27, 2026, shortly after the market closes at 4:00 p.m. ET on Tuesday, November 3, 2026.
Following the release, QuidelOrtho will hold a conference call and webcast beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the live webcast on the "Investor Relations" page of the Company's website at
https://ir.quidelortho.com/events-and-presentations
. A replay of the webcast will be available shortly after the event on the Company's website.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit
quidelortho.com
and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Sanjeev Sharma
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
Stephanie Kleewein
Senior Corporate Communications and PR Manager
media@QuidelOrtho.com
View original content to download multimedia:
https://www.prnewswire.com/news-releases/quidelortho-to-report-third-quarter-2026-financial-results-on-november-3-2026-302908607.html
SOURCE QuidelOrtho Corporation
,
Oct. 20, 2026
/PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will issue a press release to report its financial results for the third quarter 2026 ended September 27, 2026, shortly after the market closes at 4:00 p.m. ET on Tuesday, November 3, 2026.
Following the release, QuidelOrtho will hold a conference call and webcast beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the live webcast on the "Investor Relations" page of the Company's website at
https://ir.quidelortho.com/events-and-presentations
. A replay of the webcast will be available shortly after the event on the Company's website.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit
quidelortho.com
and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Sanjeev Sharma
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
Stephanie Kleewein
Senior Corporate Communications and PR Manager
media@QuidelOrtho.com
View original content to download multimedia:
https://www.prnewswire.com/news-releases/quidelortho-to-report-third-quarter-2026-financial-results-on-november-3-2026-302908607.html
SOURCE QuidelOrtho Corporation
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
aede19b0ba· 2026-10-20 20:05 · doubao / doubao-seed-evolving-latest-version · 策略包658c0c1e2ba5当前